Treatment of proliferative disorders

Details for Australian Patent Application No. 2006279929 (hide)

Owner Tetralogic Pharmaceuticals

Inventors Benetatos, Chris; Chunduru, Sri; McKinlay, Mark; Springs, Stacy

Agent Pizzeys

Pub. Number AU-A-2006279929

PCT Pub. Number WO2007/021825

Priority 60/706,649 09.08.05 US

Filing date 9 August 2006

Wipo publication date 22 February 2007

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/021825 Priority application(s): WO2007/021825

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006279938-Devices and methods for anchoring tissue

2006279906-Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof